289 related articles for article (PubMed ID: 15716397)
1. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.
Goodfellow JA; Bowes T; Sheikh K; Odaka M; Halstead SK; Humphreys PD; Wagner ER; Yuki N; Furukawa K; Furukawa K; Plomp JJ; Willison HJ
J Neurosci; 2005 Feb; 25(7):1620-8. PubMed ID: 15716397
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
[TBL] [Abstract][Full Text] [Related]
3. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
Halstead SK; O'Hanlon GM; Humphreys PD; Morrison DB; Morgan BP; Todd AJ; Plomp JJ; Willison HJ
Brain; 2004 Sep; 127(Pt 9):2109-23. PubMed ID: 15289269
[TBL] [Abstract][Full Text] [Related]
4. Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse.
Rupp A; Morrison I; Barrie JA; Halstead SK; Townson KH; Greenshields KN; Willison HJ
Exp Neurol; 2012 Feb; 233(2):836-48. PubMed ID: 22197826
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements of anti-GD1a antibodies determine their target specificity.
Lopez PH; Zhang G; Bianchet MA; Schnaar RL; Sheikh KA
Brain; 2008 Jul; 131(Pt 7):1926-39. PubMed ID: 18487279
[TBL] [Abstract][Full Text] [Related]
6. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
7. Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain-Barré syndrome.
Cunningham ME; Meehan GR; Robinson S; Yao D; McGonigal R; Willison HJ
J Peripher Nerv Syst; 2020 Jun; 25(2):143-151. PubMed ID: 32250537
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Komagamine T; Yuki N
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
[TBL] [Abstract][Full Text] [Related]
9. T cell response in acute motor axonal neuropathy.
Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Yuki N; Odaka M
Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
[TBL] [Abstract][Full Text] [Related]
11. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
[TBL] [Abstract][Full Text] [Related]
12. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice.
McGonigal R; Rowan EG; Greenshields KN; Halstead SK; Humphreys PD; Rother RP; Furukawa K; Willison HJ
Brain; 2010 Jul; 133(Pt 7):1944-60. PubMed ID: 20513658
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
[TBL] [Abstract][Full Text] [Related]
14. Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.
Fewou SN; Rupp A; Nickolay LE; Carrick K; Greenshields KN; Pediani J; Plomp JJ; Willison HJ
J Clin Invest; 2012 Mar; 122(3):1037-51. PubMed ID: 22307327
[TBL] [Abstract][Full Text] [Related]
15. The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice.
Rupp A; Cunningham ME; Yao D; Furukawa K; Willison HJ
Synapse; 2013 Jul; 67(7):382-9. PubMed ID: 23401234
[TBL] [Abstract][Full Text] [Related]
16. Anti-ganglioside antibodies alter presynaptic release and calcium influx.
Buchwald B; Zhang G; Vogt-Eisele AK; Zhang W; Ahangari R; Griffin JW; Hatt H; Toyka KV; Sheikh KA
Neurobiol Dis; 2007 Oct; 28(1):113-21. PubMed ID: 17720506
[TBL] [Abstract][Full Text] [Related]
17. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
[No Abstract] [Full Text] [Related]
18. Axonal Guillain-Barré syndrome: concepts and controversies.
Kuwabara S; Yuki N
Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
[TBL] [Abstract][Full Text] [Related]
19. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
20. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.
Halstead SK; Morrison I; O'Hanlon GM; Humphreys PD; Goodfellow JA; Plomp JJ; Willison HJ
Glia; 2005 Nov; 52(3):177-89. PubMed ID: 15968629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
